Discontinuation of antiviral therapy in chronic hepatitis B patients

Nucleos(t)ide analogs (NUC) are the first-line therapy for patients with chronic hepatitis B (CHB) recommended by most current guidelines. NUC therapy decreases progression of liver disease, reduces the risk of liver-related complications, and improves the quality of life of patients with CHB. Altho...

Descripción completa

Detalles Bibliográficos
Autores principales: Medas, Renato, Liberal, Rodrigo, Macedo, Guilherme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409197/
https://www.ncbi.nlm.nih.gov/pubmed/34540953
http://dx.doi.org/10.12998/wjcc.v9.i24.6979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409197/
https://www.ncbi.nlm.nih.gov/pubmed/34540953
http://dx.doi.org/10.12998/wjcc.v9.i24.6979

Ejemplares similares